Hanjiao Qin

786 total citations
23 papers, 618 citations indexed

About

Hanjiao Qin is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Hanjiao Qin has authored 23 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Epidemiology. Recurrent topics in Hanjiao Qin's work include Autophagy in Disease and Therapy (4 papers), Cancer Mechanisms and Therapy (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Hanjiao Qin is often cited by papers focused on Autophagy in Disease and Therapy (4 papers), Cancer Mechanisms and Therapy (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Hanjiao Qin collaborates with scholars based in China. Hanjiao Qin's co-authors include Jiyao Sheng, Xuewen Zhang, Ye Xu, Bingjin Li, Liu Shui, Jiateng Zhong, Liankun Sun, Chunyan Yu, Bingjin Li and Huimei Yu and has published in prestigious journals such as Advanced Science, Cancer Letters and Frontiers in Pharmacology.

In The Last Decade

Hanjiao Qin

21 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hanjiao Qin China	13	304	142	98	90	72	23	618
Yuxiang Han China	15	291 1.0×	45 0.3×	79 0.8×	116 1.3×	72 1.0×	38	690
Rodolfo Daniel Cervantes‐Villagrana Mexico	12	250 0.8×	47 0.3×	51 0.5×	116 1.3×	45 0.6×	26	496
Bert Grobben Belgium	12	461 1.5×	67 0.5×	70 0.7×	100 1.1×	27 0.4×	15	977
Jeong Heon Lee South Korea	14	246 0.8×	50 0.4×	66 0.7×	70 0.8×	45 0.6×	21	549
Muhlis Akman Italy	10	202 0.7×	42 0.3×	134 1.4×	105 1.2×	53 0.7×	14	453
Eun-Jin Yun United States	16	442 1.5×	89 0.6×	207 2.1×	138 1.5×	164 2.3×	25	782
Céline Delierneux Belgium	13	270 0.9×	43 0.3×	76 0.8×	110 1.2×	55 0.8×	23	599
Alireza Azimi Sweden	13	376 1.2×	63 0.4×	127 1.3×	111 1.2×	57 0.8×	19	641
Valentina Sala Italy	15	448 1.5×	82 0.6×	102 1.0×	130 1.4×	91 1.3×	24	886
Niansong Qian China	19	297 1.0×	72 0.5×	189 1.9×	272 3.0×	104 1.4×	55	899

Countries citing papers authored by Hanjiao Qin

Since Specialization

Citations

This map shows the geographic impact of Hanjiao Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanjiao Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanjiao Qin more than expected).

Fields of papers citing papers by Hanjiao Qin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanjiao Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanjiao Qin. The network helps show where Hanjiao Qin may publish in the future.

Co-authorship network of co-authors of Hanjiao Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Hanjiao Qin. A scholar is included among the top collaborators of Hanjiao Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanjiao Qin. Hanjiao Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qin, Hanjiao, et al.. (2025). Key Nano-Strategies for Cisplatin Resistance in Advancing Anti-Cancer Therapy. International Journal of Nanomedicine. Volume 20. 13255–13292.

Han, Xi, Zefeng Liu, Jie Lin, et al.. (2024). FGA influences invasion and metastasis of hepatocellular carcinoma through the PI3K/AKT pathway. Aging. 16(19). 12806–12819. 5 indexed citations

Sheng, Li, Jiyao Sheng, Dan Zhang, & Hanjiao Qin. (2024). Targeting tumor-associated macrophages to reverse antitumor drug resistance. Aging. 16(11). 10165–10196. 4 indexed citations

Wu, Jun, et al.. (2024). Advances in hepatocellular carcinoma drug resistance models. Frontiers in Medicine. 11. 1437226–1437226.

Lin, Jie, et al.. (2024). Integration of meta-analysis and network pharmacology analysis to investigate the pharmacological mechanisms of traditional Chinese medicine in the treatment of hepatocellular carcinoma. Frontiers in Pharmacology. 15. 1374988–1374988. 5 indexed citations

Qin, Hanjiao, et al.. (2023). Metabolic reprogramming induced by DCA enhances cisplatin sensitivity through increasing mitochondrial oxidative stress in cholangiocarcinoma. Frontiers in Pharmacology. 14. 1128312–1128312. 15 indexed citations

Wang, Zhenxiao, Hanjiao Qin, Shui Liu, Jiyao Sheng, & Xuewen Zhang. (2023). Precision diagnosis of hepatocellular carcinoma. Chinese Medical Journal. 136(10). 1155–1165. 32 indexed citations

Wang, Yaning, et al.. (2023). Astragaloside in cancer chemoprevention and therapy. Chinese Medical Journal. 136(10). 1144–1154. 8 indexed citations

Zhong, Jianfeng, et al.. (2022). Advances in Renal Cell Carcinoma Drug Resistance Models. Frontiers in Oncology. 12. 870396–870396. 15 indexed citations

10.

Zhang, Dan, Yicun Wang, Hanjiao Qin, et al.. (2021). Mitochondrial Quality Control in Hepatocellular Carcinoma. Frontiers in Oncology. 11. 713721–713721. 21 indexed citations

11.

Wu, Jun, Jiyao Sheng, Hanjiao Qin, et al.. (2021). The Application Progress of Patient-Derived Tumor Xenograft Models After Cholangiocarcinoma Surgeries. Frontiers in Oncology. 11. 628636–628636. 5 indexed citations

12.

Qin, Hanjiao, Haiyang Yu, Jiyao Sheng, et al.. (2019). PI3Kgamma Inhibitor Attenuates Immunosuppressive Effect of Poly(l‐Glutamic Acid)‐Combretastatin A4 Conjugate in Metastatic Breast Cancer. Advanced Science. 6(12). 1900327–1900327. 65 indexed citations

13.

Qin, Hanjiao, Linlin Liu, Shu Sun, et al.. (2018). The impact of PI3K inhibitors on breast cancer cell and its tumor microenvironment. PeerJ. 6. e5092–e5092. 42 indexed citations

14.

Sheng, Jiyao, Hanjiao Qin, Kun Zhang, Bingjin Li, & Xuewen Zhang. (2018). Targeting autophagy in chemotherapy-resistant of hepatocellular carcinoma.. PubMed. 8(3). 354–365. 47 indexed citations

15.

Sheng, Jiyao, Liu Shui, Hanjiao Qin, Bingjin Li, & Xuewen Zhang. (2017). Drug-Resistant Epilepsy and Surgery. Current Neuropharmacology. 16(1). 17–28. 98 indexed citations

16.

Qin, Hanjiao, Zhuo Li, Limei Qu, et al.. (2015). A rare case of focal nesidioblastosis causing adult-onset hypoglycemia. Experimental and Therapeutic Medicine. 10(2). 723–726. 4 indexed citations

17.

Qin, Hanjiao, Ze Zhang, Ye Xu, et al.. (2015). Valproate attenuates diabetic nephropathy through inhibition of endoplasmic reticulum stress-induced apoptosis. Molecular Medicine Reports. 13(1). 661–668. 50 indexed citations

18.

Qin, Hanjiao, Wei Liu, Zhou Ye, et al.. (2013). Human umbilical cord mesenchymal stem cell-loaded amniotic membrane for the repair of radial nerve injury.. PubMed. 8(36). 3441–8. 21 indexed citations

19.

Xu, Ye, Huimei Yu, Hanjiao Qin, et al.. (2011). Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells. Cancer Letters. 314(2). 232–243. 138 indexed citations

20.

Zhang, Weizhong, et al.. (2011). Inhibition of cytohesin-1 by siRNA leads to reduced IGFR signaling in prostate cancer. Brazilian Journal of Medical and Biological Research. 44(7). 642–646. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact